ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Stemedica Opens Enrollment in Phase II Clinical Trial for COVID-19 prnewswire
August 06, 2021Stemedica announces enrollment of patients for its study entitled "A Phase II, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Moderate.
Pharma Sources Insight January 2025
